People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Voltron Therapeutics, Inc. | — | Biotechnology | Seed | $9.4M | $39.4M | 2019 |
| Algorithm Sciences, Inc. | — | Biotechnology | Seed | $7.2M | $1.9M | 2019 |
| Aerwave Medical, Inc. | — | Healthtech | Seed | $5.5M | $45.1M | 2022 |
| PD Theranostics, Inc. | — | Biotechnology | Pre-Seed | $508K | $5.6M | 2022 |
James Ahern at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Ahern on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Gallagher | 4 | 11 |
| Matthew Duffy | 4 | 5 |
| Jeffrey O'Donnell | 2 | 7 |
| Anthony Zook | 2 | 4 |
| Matthew Eitner | 2 | 3 |
| Paul Korner | 1 | 2 |
| Jeff O?Donnell | 1 | 2 |
| David Cavalier | 1 | 2 |
| Craig K. Carra | 1 | 2 |
| Gary Gemignani | 1 | 1 |
| Kamal Mubarak | 1 | 1 |
| Gary Gemigani | 1 | 1 |
| Michael Tilton | 1 | 1 |
| Tony Hodges | 1 | 1 |
| Reinhard Warnking | 1 | 1 |
| Kamal Mubark | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.